Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Journal of Autoimmune Diseases

Figure 1

From: Islet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study

Figure 1

Prevalence of any antibody in patients with different durations of diabetes (time intervals since diagnosis). In patients with T1D, the prevalence of any antibody was highest {n = 9, (50%)} in the 1–2 year interval of the disease, and thereafter dropped slightly. In patients with T2D the prevalence was lowest in the 1–2 year interval of the disease, and slightly increased thereafter. There was no inverse correlation between duration of disease and autoantibodies in the patients with T1D.

Back to article page